T. Kuritani

发表

Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study.

T. Kishimoto, K. Yoshizaki, N. Nishimoto, 2003, The Journal of rheumatology.

A new highly sensitive immunoassay for cytokines by dissociation-enhanced lanthanide fluoroimmunoassay (DELFIA).

M. Kurimoto, A. Ogata, T. Kishimoto, 1992, Journal of immunological methods.

In vitro immune response of human peripheral lymphocytes. I. The mechanism(s) involved in T cell helper functions in the pokeweed mitogen-induced differentiation and proliferation of B cells.

T. Hirano, T. Kishimoto, Y. Yamamura, 1977, Journal of immunology.

A case report of a patient with rheumatoid arthritis complicated with Mycobacterium avium during tocilizumab treatment

S. Higa, K. Kawamoto, K. Maeda, 2011, Modern rheumatology.

A case report of a patient with rheumatoid arthritis complicated with Mycobacterium avium during tocilizumab treatment

S. Higa, K. Kawamoto, K. Maeda, 2011, Modern rheumatology.

Improvement of health status evaluated by Arthritis Impact Measurement Scale 2 (AIMS-2) and Short Form-36 (SF-36) in patients with rheumatoid arthritis treated with tocilizumab

S. Higa, K. Kawamoto, K. Maeda, 2013 .

T cell-replacing factor- (TRF) induced IgG secretion in a human B blastoid cell line and demonstration of acceptors for TRF.

T. Kishimoto, A. Muraguchi, K. Yoshizaki, 1981, Journal of immunology.

Psychological state is related to the remission of the Boolean-based definition of patient global assessment in patients with rheumatoid arthritis

K. Maeda, Y. Miura, H. Sano, 2015, Modern rheumatology.

Improvement of health status evaluated by Arthritis Impact Measurement Scale 2 (AIMS-2) and Short Form-36 (SF-36) in patients with rheumatoid arthritis treated with tocilizumab

S. Higa, K. Kawamoto, K. Maeda, 2013, Modern rheumatology.

Interleukin-6 in autoimmune disorders.

T. Kishimoto, K. Yoshizaki, T. Kuritani, 1992, Seminars in immunology.

B Cell Growth and Differentiation Factors and Mechanism of B Cell Activation

H. Kikutani, M. Kimoto, T. Kishimoto, 1984, Immunological reviews.

disease Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's

T. Komori, T. Matsuda, K. Aozasa, 2011 .

Decreased expression of interleukin-2 binding molecules (p70/75) in T cells from patients with systemic lupus erythematosus.

H. Hara, T. Tanaka, S. Kishimoto, 1989, Arthritis and rheumatism.

In Vitro Immune Response of Human Peripheral Lymphocytes

T. Hirano, T. Kishimoto, Y. Yamamura, 1977, Microbiology and immunology.

Interleukin 6 and expression of its receptor on epidermal keratinocytes.

K. Matsumoto, K. Hashimoto, T. Hirano, 1990, Cytokine.

In vitro induction of IgM secretion and switching to IgG production in human B leukemic cells with the help of T cells.

T. Kishimoto, A. Muraguchi, T. Kuritani, 1980, Journal of immunology.

In vitro immune response of human peripheral lymphocytes. V. PHA- and protein A-induced human B colony formation and analysis of the subpopulations of B cells.

T. Kishimoto, A. Muraguchi, Y. Yamamura, 1980, Journal of immunology.

High Sensitivity to Peripheral Blood Lymphocytes and Low HLA‐class I Antigen Expression of Small Cell Lung Cancer Cell Lines with Diverse Chemo‐radiosensitivity

I. Kawase, T. Kishimoto, Masatoshi Watanabe, 1992, Japanese journal of cancer research : Gann.

T-cell regulation of IgG subclass expression by mitogen-induced plasma cells: Soluble factors versus the T cells

M. Cooper, T. Kuritani, M. Mayumi, 1984, Journal of Clinical Immunology.

Human B cell differentiation. IV. Effect of monoclonal anti-immunoglobulin M and D antibodies on B cell proliferation and differentiation induced by T cell factors.

M. Cooper, T. Kuritani, 1983, Journal of immunology.

Human B cell differentiation. II. Pokeweed mitogen-responsive B cells belong to a surface immunoglobulin D-negative subpopulation

M. Cooper, T. Kuritani, 1982, The Journal of experimental medicine.

Depressed functions of T cells and the presence of suppressor macrophages in patients with sarcoidosis.

T. Kishimoto, H. Kishi, A. Muraguchi, 1982, Clinical immunology and immunopathology.

Elevated levels of interleukin-6 in serum and cerebrospinal fluid of HTLV-I-associated myelopathy/tropical spastic paraparesis

A. Ogata, T. Kishimoto, H. Tagoh, 1990, Journal of the Neurological Sciences.

Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease

T. Komori, T. Matsuda, K. Aozasa, 1989 .

IgG subclass expression by human B lymphocytes and plasma cells: B lymphocytes precommitted to IgG subclass can be preferentially induced by polyclonal mitogens with T cell help.

M. Cooper, H. Kubagawa, T. Kuritani, 1983, Journal of immunology.

In vitro immune response of human peripheral lymphocytes. IV. Specific induction of human suppressor T cells by an antiserum to the T leukemia cell line HSB.

T. Hirano, P. Ralph, T. Kishimoto, 1979, Journal of immunology.

Induction of IgG production in human B lymphoblastoid cell lines with normal human T cells

T. Hirano, P. Ralph, T. Kishimoto, 1978, Nature.

Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease.

T. Komori, T. Hirano, T. Matsuda, 1989, Blood.

Human b-cell differentiation. I. Analysis of immunoglobulin heavy chain switching using monoclonal anti-immunoglobulin M, G, and A antibodies and pokeweed mitogen-induced plasma cell differentiation

M. Cooper, T. Kuritani, 1982, The Journal of experimental medicine.

In vitro immune response of human peripheral lymphocytes. VI. Distribution and characterization of precursors for PHA- and protein A-induced colony-forming B cells.

T. Kishimoto, A. Muraguchi, Y. Yamamura, 1980, Journal of immunology.

DEFICIENT IgA SYNTHESIS VIEWED IN THE CONTEXT OF NORMAL DEVELOPMENT OF IgA B‐CELLS

D. Briles, W. Gathings, T. Kuritani, 1983, Annals of the New York Academy of Sciences.

EXPRESSION OF IgD AS A FUNCTION OF B‐CELL DIFFERENTIATION *

M. Cooper, W. Gathings, T. Kuritani, 1982, Annals of the New York Academy of Sciences.

Pathogenic significance of BSF-2/IL-6 in castleman's disease

T. Komori, T. Matsuda, T. Hirano, 1988 .

Human B cell differentiation. III. Enhancing effect of monoclonal anti-immunoglobulin D antibody on pokeweed mitogen-induced plasma cell differentiation.

M. Cooper, T. Kuritani, 1982, Journal of immunology.